A detailed history of State Of New Jersey Common Pension Fund D transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, State Of New Jersey Common Pension Fund D holds 22,411 shares of AXSM stock, worth $2.03 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
22,411
Previous 24,729 9.37%
Holding current value
$2.03 Million
Previous $1.99 Million 1.16%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$78.93 - $95.84 $182,959 - $222,157
-2,318 Reduced 9.37%
22,411 $2.01 Million
Q2 2024

Aug 07, 2024

SELL
$65.72 - $80.5 $601,206 - $736,414
-9,148 Reduced 27.0%
24,729 $1.99 Million
Q1 2024

May 02, 2024

SELL
$69.39 - $97.64 $289,495 - $407,354
-4,172 Reduced 10.96%
33,877 $2.7 Million
Q4 2023

Feb 02, 2024

BUY
$57.42 - $83.61 $320,173 - $466,209
5,576 Added 17.17%
38,049 $3.03 Million
Q2 2023

Aug 02, 2023

SELL
$58.41 - $90.35 $269,036 - $416,152
-4,606 Reduced 12.42%
32,473 $2.33 Million
Q1 2023

Apr 26, 2023

BUY
$58.39 - $75.0 $2.17 Million - $2.78 Million
37,079 New
37,079 $2.29 Million
Q3 2022

Oct 28, 2022

BUY
$36.06 - $69.85 $1.26 Million - $2.45 Million
35,009 New
35,009 $1.56 Million
Q2 2021

Jul 23, 2021

SELL
$50.63 - $73.5 $1.62 Million - $2.36 Million
-32,042 Closed
0 $0
Q1 2021

Apr 27, 2021

BUY
$55.91 - $81.44 $131,835 - $192,035
2,358 Added 7.94%
32,042 $1.81 Million
Q4 2020

Feb 03, 2021

BUY
$66.31 - $86.52 $11,206 - $14,621
169 Added 0.57%
29,684 $2.42 Million
Q3 2020

Oct 27, 2020

BUY
$68.34 - $85.84 $427,398 - $536,843
6,254 Added 26.89%
29,515 $2.1 Million
Q2 2020

Aug 04, 2020

BUY
$49.87 - $98.69 $1.16 Million - $2.3 Million
23,261 New
23,261 $1.91 Million

Others Institutions Holding AXSM

About Axsome Therapeutics, Inc.


  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $3.89B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track State Of New Jersey Common Pension Fund D Portfolio

Follow State Of New Jersey Common Pension Fund D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

News

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.